financetom
Business
financetom
/
Business
/
CFIB Comments on The Pause in Canada-U.S. Trade Tariffs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CFIB Comments on The Pause in Canada-U.S. Trade Tariffs
Feb 4, 2025 5:35 AM

08:08 AM EST, 02/04/2025 (MT Newswires) -- Monday's announcement of a pause in the use of tariffs in Canada-United States trade is a welcome relief for small businesses, said the Canadian Federation of Independent Business (CFIB).

However, as the threat of tariffs continues to loom, the ongoing uncertainty will make it challenging for small business owners to plan and make decisions around their operations, noted CFIB.

While Canada catches its breath and implements the border measures, CFIB stated it can't afford to take its eyes off the many other critical changes needed to prepare for the future.

This means Canada needs to seize the opportunity now to bring in policies that improve its investment climate, reduce taxes, slash red tape and break down internal trade barriers to ensure businesses are prepared no matter what external threats comes along, it added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Certara Buys Cheminformatics Software Firm, Expanding Drug-Discovery Offerings
Certara Buys Cheminformatics Software Firm, Expanding Drug-Discovery Offerings
Jul 9, 2024
05:19 PM EDT, 07/09/2024 (MT Newswires) -- Certara ( CERT ) late Tuesday said it has signed a definitive agreement to acquire Chemaxon, a privately held cheminformatics software developer. The deal should close during the second half of 2024, subject to regulatory approval and other customary closing conditions. Financial terms were not disclosed. Chemaxon is developing software products providing chemical...
Arcutis Biotherapeutics' Zoryve Gets US FDA Approval for Atopic Dermatitis
Arcutis Biotherapeutics' Zoryve Gets US FDA Approval for Atopic Dermatitis
Jul 9, 2024
05:18 PM EDT, 07/09/2024 (MT Newswires) -- Arcutis Biotherapeutics ( ARQT ) said Tuesday that the US Food and Drug Administration approved Zoryve to treat mild to moderate atopic dermatitis in adults and pediatric patients six years and older. The supplemental new drug application for Zoryve was supported by results from three phase three clinical studies including Intengument-1 and Intengument-2,...
ChampionX Completes Acquisition of RMSpumptools
ChampionX Completes Acquisition of RMSpumptools
Jul 9, 2024
05:25 PM EDT, 07/09/2024 (MT Newswires) -- ChampionX ( CHX ) said late Tuesday it has completed the acquisition of RMSpumptools, expanding its production and automation technologies portfolio. Financial terms of the acquisition weren't disclosed. RMSpumptools manufactures products such as artificial lift sensors and subsea connectors for the oil and gas industry. ...
Playa Hotels & Resorts Reports No Significant Damage From Hurricane Beryl
Playa Hotels & Resorts Reports No Significant Damage From Hurricane Beryl
Jul 9, 2024
05:18 PM EDT, 07/09/2024 (MT Newswires) -- Playa Hotels & Resorts ( PLYA ) said Tuesday that its resorts in the Caribbean and Mexico did not sustain significant damage from Hurricane Beryl following an initial evaluation. All of its resorts are currently open, operational, and welcoming guests, the company said. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved